The Challenges in Treating TD: Underdiagnosed & Unrecognized
Jonathan Meyer, MD Clinical Professor of Psychiatry University of California San Diego Chirag...
Read More
Author: Janine Anthes
PhysQuiz on APA 2021: Tardive Dyskinesia
Are you caught up on trials on tardive dyskinesia presented on APA 2021? Test your knowledge! 1. A...
Read More
The Role of VMAT2 Inhibitors in Managing TD During Schizophrenia Treatment
Chirag Shah, PharmD, RPh Head Medical Affairs & Medical Education Neurocrine Biosciences...
Read More
PhysQuiz on AAN 2021: Multiple Sclerosis
Are you caught up on trials on multiple sclerosis that have been released from AAN 2021? Test your...
Read More
Identifying Patients with Tardive Dyskinesia
Jonathan Meyer, MD Clinical Professor of Psychiatry University of California San Diego ...
Read More
PhysQuiz Answers! A Focus on Tardive Dyskinesia
Thank you for taking our medical quiz on Tardive Dyskinesia! How did you do? According to an interview with Jonathan Meyer, MD, Clinical Professor of Psychiatry at UCSD, risk factors for developing tardive dyskinesia do...
Read MorePatients with TD More Worried about Mental Health than Movement
Although assessing and reducing the severity of tardive dyskinesia (TD)—a persistent and potentially disabling movement disorder linked with exposure to antipsychotics and other dopamine receptor blocking agents—is crucial for...
Read MorePhysQuiz Answers! A Focus on Multiple Sclerosis
1. Which of the following is a finding of the study for which researchers tested associations between age-specific diet and case-control status among adults aged 18 and older with recent-onset MS and matched controls? a)...
Read More
Q&A with Dr. McEvoy and Dr. Meyer on Tardive Dyskinesia
Physician’s Weekly interviews Joseph McEvoy, MD, Professor Emeritus of Psychiatry and...
Read More
Bio: Joseph P. McEvoy, MD
Joseph Patrick McEvoy, MD Professor Emeritus of Psychiatry and Behavioral Sciences Psychiatry...
Read More
New Poll: Patients Confident in Telepsychiatry
Many Americans have used telehealth and would turn to it for mental health care, a new online poll...
Read MoreNeurofilament light outperforms total tau as biomarker for neurodegeneration
Plasma neurofilament light chain (NfL) demonstrated to be a more valuable biomarker for neurodegeneration than total tau (T-tau) protein. This was the conclusion of the Mayo Clinic Study of Aging (MCSA), comparing the 2...
Read MoreNo link between antidepressants and intracerebral hemorrhage in stroke patients
No association was found between the use of antidepressants (AD) and the occurrence of intracerebral hemorrhage (ICH) in a large population-based study of the Florida Stroke Registry (FSR), a voluntary stroke registry of Florida...
Read MoreObstructive sleep apnea common in cognitively impaired population
Obstructive sleep apnea (OSA) is prevalent among cognitively impaired patients and linked to reduced sleep quality and lowered cognitive capacities. David Colelli (University of Toronto, Canada) presented the results of his...
Read MoresNfL projects development of definite MS
In patients who experienced a first clinical demyelinating event, baseline levels of serum neurofilament light chain (sNfL), a biomarker of neural damage, were associated with conversion to McDonald 2005 multiple sclerosis (MS)....
Read MoreMast cell and neutrophil involvement in the disease activity of MS
Preliminary results of a genome-wide-association study (GWAS) show a possible involvement of mast cells and neutrophils in the disease activity of relapsing-remitting MS patients [1]. These results provide important knowledge on...
Read MoreThe role of brain ATP abnormalities in MS disease progression
A 3-year prospective observational study investigating ATP changes in MS via T7 MRSI, comparing patients with and without vascular disease risk factors (VDRF), demonstrated that VDRF-positive patients had lower brain ATP rates...
Read More